Howell F. Moffett, Ph.D. - Publications

Affiliations: 
2012 Biology: Medical Sciences, Division of Harvard University, Cambridge, MA, United States 
Area:
T Cell Biology and Cancer Immunology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Moffett HF, Smith TT, Stephan MT. Abstract IA07: Genetic engineering of therapeutic T cells using synthetic nanoparticles Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-Ia07  0.39
2017 Moffett HF, Cartwright ANR, Kim HJ, Godec J, Pyrdol J, Äijö T, Martinez GJ, Rao A, Lu J, Golub TR, Cantor H, Sharpe AH, Novina CD, Wucherpfennig KW. Erratum: The microRNA miR-31 inhibits CD8(+) T cell function in chronic viral infection. Nature Immunology. 18: 1173. PMID 28926530 DOI: 10.1038/ni1017-1173d  0.542
2017 Moffett HF, Coon ME, Radtke S, Stephan SB, McKnight L, Lambert A, Stoddard BL, Kiem HP, Stephan MT. Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers. Nature Communications. 8: 389. PMID 28855514 DOI: 10.1038/S41467-017-00505-8  0.336
2017 Moffett HF, Cartwright ANR, Kim HJ, Godec J, Pyrdol J, Äijö T, Martinez GJ, Rao A, Lu J, Golub TR, Cantor H, Sharpe AH, Novina CD, Wucherpfennig KW. The microRNA miR-31 inhibits CD8(+) T cell function in chronic viral infection. Nature Immunology. PMID 28530712 DOI: 10.1038/Ni.3755  0.581
2017 Smith TT, Moffett HF, Stephan SB, Opel CF, Dumigan AG, Jiang X, Pillarisetty VG, Pillai SPS, Wittrup KD, Stephan MT. Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors. The Journal of Clinical Investigation. PMID 28436934 DOI: 10.1172/Jci87624  0.415
2017 Smith TT, Stephan SB, Moffett HF, McKnight LE, Ji W, Reiman D, Bonagofski E, Wohlfahrt ME, Pillai SPS, Stephan MT. In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers. Nature Nanotechnology. PMID 28416815 DOI: 10.1038/Nnano.2017.57  0.381
2015 Kim HJ, Barnitz RA, Kreslavsky T, Brown FD, Moffett H, Lemieux ME, Kaygusuz Y, Meissner T, Holderried TA, Chan S, Kastner P, Haining WN, Cantor H. Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science (New York, N.Y.). 350: 334-9. PMID 26472910 DOI: 10.1126/Science.Aad0616  0.405
2011 Li S, Moffett HF, Lu J, Werner L, Zhang H, Ritz J, Neuberg D, Wucherpfennig KW, Brown JR, Novina CD. MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. Plos One. 6: e16956. PMID 21408091 DOI: 10.1371/Journal.Pone.0016956  0.53
2009 Cosmopoulos K, Pegtel M, Hawkins J, Moffett H, Novina C, Middeldorp J, Thorley-Lawson DA. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. Journal of Virology. 83: 2357-67. PMID 19091858 DOI: 10.1128/Jvi.02104-08  0.305
2008 Love TM, Moffett HF, Novina CD. Not miR-ly small RNAs: big potential for microRNAs in therapy. The Journal of Allergy and Clinical Immunology. 121: 309-19. PMID 18269923 DOI: 10.1016/J.Jaci.2007.12.1167  0.315
2007 Moffett HF, Novina CD. A small RNA makes a Bic difference. Genome Biology. 8: 221. PMID 17666120 DOI: 10.1186/Gb-2007-8-7-221  0.34
2006 Norris PJ, Stone JD, Anikeeva N, Heitman JW, Wilson IC, Hirschkorn DF, Clark MJ, Moffett HF, Cameron TO, Sykulev Y, Stern LJ, Walker BD. Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope. Molecular Immunology. 43: 1349-57. PMID 16216327 DOI: 10.1016/J.Molimm.2005.09.004  0.398
2005 Feng J, Garrity D, Call ME, Moffett H, Wucherpfennig KW. Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors. Immunity. 22: 427-38. PMID 15845448 DOI: 10.1016/J.Immuni.2005.02.005  0.526
2004 Norris PJ, Moffett HF, Yang OO, Kaufmann DE, Clark MJ, Addo MM, Rosenberg ES. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells. Journal of Virology. 78: 8844-51. PMID 15280492 DOI: 10.1128/Jvi.78.16.8844-8851.2004  0.441
2004 SenGupta D, Norris PJ, Suscovich TJ, Hassan-Zahraee M, Moffett HF, Trocha A, Draenert R, Goulder PJ, Binder RJ, Levey DL, Walker BD, Srivastava PK, Brander C. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II. Journal of Immunology (Baltimore, Md. : 1950). 173: 1987-93. PMID 15265933 DOI: 10.4049/Jimmunol.173.3.1987  0.355
2004 Norris PJ, Moffett HF, Brander C, Allen TM, O'Sullivan KM, Cosimi LA, Kaufmann DE, Walker BD, Rosenberg ES. Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells. Aids Research and Human Retroviruses. 20: 315-25. PMID 15117455 DOI: 10.1089/088922204322996554  0.428
2001 Norris PJ, Sumaroka M, Brander C, Moffett HF, Boswell SL, Nguyen T, Sykulev Y, Walker BD, Rosenberg ES. Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones. Journal of Virology. 75: 9771-9. PMID 11559810 DOI: 10.1128/Jvi.75.20.9771-9779.2001  0.447
Show low-probability matches.